Is treatment-resistant depression really resistant?

Neuroscience-based nomenclature of psychotropics: Progress report

(2022) Joseph Zohar et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

When depression is difficult to treat

(2022) R.H. McAllister-Williams   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Treatment Response of Add-On Esketamine Nasal Spray in Resistant Major Depression in Relation to Add-On Second-Generation Antipsychotic Treatment

(2020) Markus Dold et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study

(2019) Vanina Popova et al.   AMERICAN JOURNAL OF PSYCHIATRY

Prognosis and improved outcomes in major depression: a review

(2019) Christoph Kraus et al.   Translational Psychiatry

Results of the European Group for the Study of Resistant Depression (GSRD) — basis for further research and clinical practice

(2019) Lucie Bartova et al.   WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY

Clinical factors predicting treatment resistant depression: affirmative results from the European multicenter study

(2018) A. Kautzky et al.   ACTA PSYCHIATRICA SCANDINAVICA

Clinical factors associated with augmentation treatment with second-generation antipsychotics and lithium in major depression – Results from a European multicenter study

(2018) Markus Dold et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY